TENOR CAPITAL MANAGEMENT Co. L.P. acquired a new position in Integer Holdings Corporation (NYSE:ITGR - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 41,188 shares of the medical equipment provider's stock, valued at approximately $4,861,000. TENOR CAPITAL MANAGEMENT Co. L.P. owned 0.12% of Integer as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Cubist Systematic Strategies LLC purchased a new stake in shares of Integer in the first quarter worth $1,035,000. Paradigm Capital Management Inc. NY increased its position in shares of Integer by 426.2% during the first quarter. Paradigm Capital Management Inc. NY now owns 22,100 shares of the medical equipment provider's stock valued at $2,608,000 after acquiring an additional 17,900 shares in the last quarter. DRW Securities LLC purchased a new position in shares of Integer in the first quarter worth $220,000. The Manufacturers Life Insurance Company lifted its holdings in shares of Integer by 40.2% during the first quarter. The Manufacturers Life Insurance Company now owns 213,741 shares of the medical equipment provider's stock valued at $25,224,000 after purchasing an additional 61,273 shares in the last quarter. Finally, Magnetar Financial LLC purchased a new stake in shares of Integer during the first quarter valued at $680,000. Hedge funds and other institutional investors own 99.29% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts have weighed in on the stock. Citigroup upgraded shares of Integer from a "hold" rating to a "strong-buy" rating and boosted their target price for the company from $133.00 to $140.00 in a research note on Thursday, May 22nd. Truist Financial reduced their price objective on Integer from $145.00 to $137.00 and set a "buy" rating for the company in a research report on Friday, July 25th. Wall Street Zen raised Integer from a "hold" rating to a "buy" rating in a report on Saturday, August 30th. Raymond James Financial cut their price target on Integer from $150.00 to $143.00 and set an "outperform" rating for the company in a research note on Friday, July 25th. Finally, Wells Fargo & Company dropped their price target on shares of Integer from $152.00 to $132.00 and set an "overweight" rating on the stock in a research note on Friday, July 25th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat.com, Integer presently has an average rating of "Buy" and a consensus price target of $140.25.
Check Out Our Latest Stock Analysis on ITGR
Integer Price Performance
Shares of NYSE ITGR traded up $0.22 during mid-day trading on Friday, reaching $106.82. The company's stock had a trading volume of 317,647 shares, compared to its average volume of 259,769. The stock has a fifty day moving average of $111.29 and a two-hundred day moving average of $116.77. The firm has a market capitalization of $3.74 billion, a PE ratio of 47.06, a P/E/G ratio of 0.84 and a beta of 1.03. Integer Holdings Corporation has a 52 week low of $104.93 and a 52 week high of $146.36. The company has a debt-to-equity ratio of 0.72, a current ratio of 3.41 and a quick ratio of 2.18.
Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings data on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.02). The company had revenue of $476.00 million for the quarter, compared to the consensus estimate of $464.37 million. Integer had a net margin of 4.61% and a return on equity of 12.27%. The company's quarterly revenue was up 11.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.30 EPS. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. As a group, sell-side analysts anticipate that Integer Holdings Corporation will post 6.01 EPS for the current fiscal year.
Integer Company Profile
(
Free Report)
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Featured Stories

Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.